Creating shared value as a new business model for pharmaceutical companies    Glaxo Smith Kline(GSK) MODEL "

Please use this identifier to cite or link to this item: https://dspace.univ-ouargla.dz/jspui/handle/123456789/10128

Full metadata record

DC Field	Value	Language
dc.contributor.author	Ishak KHERCHI	-
dc.contributor.author	Mohamed FELLAGUE	-
dc.date.accessioned	2015-12	-
dc.date.available	2015-12	-
dc.date.issued	2015-12	-
dc.identifier.issn	5302/2392	-
dc.identifier.uri	http://dspace.univ-ouargla.dz/jspui/handle/123456789/10128	-
dc.description	Algerian Review of Economic Development (ARED)	en_US
dc.description.abstract	This paper aims to provide shared value as a new business model for pharmaceutical companies to create social and economic value. Based on the dedicative approach we analysed Glaxo smith kline programs that created shared value, we provide new way of doing business for pharmaceutical companies.	en_US
dc.language.iso	fr	en_US
dc.relation.ispartofseries	Number 03 Déc 2015;	-
dc.subject	Shared value	en_US
dc.subject	Social value	en_US
dc.subject	Business value	en_US
dc.subject	business model	en_US
dc.subject	Glaxo smith Kline	en_US
dc.title	Creating shared value as a new business model for pharmaceutical companies Glaxo Smith Kline(GSK) MODEL "	en_US
dc.type	Article	en_US
Appears in Collections:	Number 03 Déc 2015

Files in This Item:

File	Description	Size	Format
AERD0312f.pdf		453,84 kB	Adobe PDF	View/Open

DSpace JSPUI